0001654954-22-001167.txt : 20220204 0001654954-22-001167.hdr.sgml : 20220204 20220204192956 ACCESSION NUMBER: 0001654954-22-001167 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220202 FILED AS OF DATE: 20220204 DATE AS OF CHANGE: 20220204 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cittadine Andrew CENTRAL INDEX KEY: 0001863624 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39070 FILM NUMBER: 22595171 MAIL ADDRESS: STREET 1: C/O 1000 SKOKIE BLVD SUITE 350 CITY: WILMETTE STATE: IL ZIP: 60091 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Monopar Therapeutics CENTRAL INDEX KEY: 0001645469 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 320463781 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1000 SKOKIE BLVD SUITE 350 CITY: WILMETTE STATE: IL ZIP: 60091 BUSINESS PHONE: 8473880349 MAIL ADDRESS: STREET 1: 1000 SKOKIE BLVD SUITE 350 CITY: WILMETTE STATE: IL ZIP: 60091 4 1 section16.xml PRIMARY DOCUMENT X0306 4 2022-02-02 false 0001645469 Monopar Therapeutics MNPR 0001863624 Cittadine Andrew 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091 false true false false Chief Operating Officer Stock Options 2.80 2022-02-02 4 A false 85000 0 A 2032-02-01 Common Stock 85000 85000 D Restricted Stock Units 0 2022-02-02 4 A false 65000 0 A Common Stock 65000 65000 D Options vest 6/48ths on June 30, 2022 and 1/48ths per month thereafter. RSUs vest 6/48ths on June 30, 2022 and 3/48ths per quarter thereafter (September 30, 2022, December 31, 2022, March 31, 2023, June 30, 2023, September 30, 2023, December 31, 2023, March 31, 2024, June 30, 2024, September 30, 2024, December 31, 2024, March 31, 2025, June 30, 2025, September 30, 2025, December 31, 2025) /s/ Kim R. Tsuchimoto, Attorney-in-Fact 2022-02-04